Decheng Capital Global Healthcare Fund (Master), LP is > 10% Shareholder of ALPINE IMMUNE SCIENCES, INC.. Currently has a direct ownership of 1.74 Million shares of ALPN, which is worth approximately $0. The most recent transaction as insider was on Nov 09, 2023, when has been sold 375,000 shares (Common Stock) at a price of $12.5 per share, resulting in proceeds of $4,687,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.74M
0% 3M change
0% 12M change
Total Value Held $0

Decheng Capital Global Healthcare Fund (Master), LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 09 2023
BUY
Open market or private purchase
$4,687,500 $12.5 p/Share
375,000 Added 17.77%
1,735,544 Common Stock
DCG

Decheng Capital Global Healthcare Fund (Master), LP

> 10% Shareholder
Grand Cayman, E9

Track Institutional and Insider Activities on ALPN

Follow ALPINE IMMUNE SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALPN shares.

Notify only if

Insider Trading

Get notified when an Alpine Immune Sciences, Inc. insider buys or sells ALPN shares.

Notify only if

News

Receive news related to ALPINE IMMUNE SCIENCES, INC.

Track Activities on ALPN